Europe Non-Alcoholic Steatopatitis Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Non-Alcoholic Steatopatitis Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Non-Alcoholic Steatopatitis Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Non-Alcoholic Steatopatitis Market Regional Analysis

6.2 Europe Non-Alcoholic Steatopatitis Market Revenue 2019-2028 (US$ Million)

6.3 Europe Non-Alcoholic Steatopatitis Market Forecast Analysis

7. Europe Non-Alcoholic Steatopatitis Market Analysis – by Product

7.1 Vitamin E and Pioglitazone

7.1.1 Overview
7.1.2 Vitamin E and Pioglitazone: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Ocaliva

7.2.1 Overview
7.2.2 Ocaliva: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Elafibranor

7.3.1 Overview
7.3.2 Elafibranor: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.4 Selonsertib

7.4.1 Overview
7.4.2 Selonsertib: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.5 Cenicriviroc

7.5.1 Overview
7.5.2 Cenicriviroc: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Non-Alcoholic Steatopatitis Market Analysis – by Application

8.1 Treatment

8.1.1 Overview
8.1.2 Treatment: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

8.2 Diagnosis

8.2.1 Overview
8.2.2 Diagnosis: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Non-Alcoholic Steatopatitis Market Analysis – by Sales Channel

9.1 Hospital Pharmacy

9.1.1 Overview
9.1.2 Hospital Pharmacy: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.2 Online Provider

9.2.1 Overview
9.2.2 Online Provider: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

9.3 Retail Pharmacy

9.3.1 Overview
9.3.2 Retail Pharmacy : Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast, 2019-2028 (US$ Million)

10. Europe Non-Alcoholic Steatopatitis Market – Europe Analysis

10.1 Overview

10.2 Europe

10.2.1 Europe Non-Alcoholic Steatopatitis Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast Analysis – by Country
10.2.1.1 UK: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 UK: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Product
10.2.1.1.2 UK: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Application
10.2.1.1.3 UK: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Sales Channel

10.2.1.2 Germany: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Germany: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Product
10.2.1.2.2 Germany: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Application
10.2.1.2.3 Germany: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Sales Channel

10.2.1.3 France: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 France: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Product
10.2.1.3.2 France: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Application
10.2.1.3.3 France: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Sales Channel

10.2.1.4 Russia: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.4.1 Russia: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Product
10.2.1.4.2 Russia: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Application
10.2.1.4.3 Russia: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Sales Channel

10.2.1.5 Italy: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.5.1 Italy: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Product
10.2.1.5.2 Italy: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Application
10.2.1.5.3 Italy: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Sales Channel

10.2.1.6 Rest of Europe: Europe Non-Alcoholic Steatopatitis Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.6.1 Rest of Europe: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Product
10.2.1.6.2 Rest of Europe: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Application
10.2.1.6.3 Rest of Europe: Europe Non-Alcoholic Steatopatitis Market Breakdown, by Sales Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Cadila Pharmaceutical.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Intercept Pharmaceutical.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Novartis AG.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Galmed Pharmaceutical.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 GENFIT.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 ONE WAY LIVER SI.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 BioPredictive S.A.S.

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Siemens Healthineers AG.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Laboratory Corporation of America Holdings.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Europe Non-Alcoholic Steatopatitis Market

Analysis By Product (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Application (Treatment and Diagnosis), and Sales Channel (Hospital Pharmacy, Online Provider, and Retail Pharmacy)